Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,173,100
  • Shares Outstanding, K 56,007
  • Annual Sales, $ 638,760 K
  • Annual Income, $ 41,580 K
  • EBIT $ 7 M
  • EBITDA $ 78 M
  • 60-Month Beta 0.96
  • Price/Sales 12.80
  • Price/Cash Flow 48.24
  • Price/Book 4.12

Options Overview Details

View History
  • Implied Volatility 61.68% ( +0.91%)
  • Historical Volatility 38.10%
  • IV Percentile 95%
  • IV Rank 87.80%
  • IV High 65.72% on 11/04/24
  • IV Low 32.53% on 05/17/24
  • Put/Call Vol Ratio 0.63
  • Today's Volume 13
  • Volume Avg (30-Day) 316
  • Put/Call OI Ratio 1.13
  • Today's Open Interest 6,859
  • Open Int (30-Day) 6,423

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.34
  • Number of Estimates 6
  • High Estimate 0.38
  • Low Estimate 0.29
  • Prior Year 0.23
  • Growth Rate Est. (year over year) +47.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
133.34 +7.63%
on 10/10/24
154.11 -6.87%
on 10/17/24
+6.93 (+5.07%)
since 10/07/24
3-Month
133.34 +7.63%
on 10/10/24
166.97 -14.04%
on 08/08/24
-18.97 (-11.67%)
since 08/07/24
52-Week
113.50 +26.45%
on 06/20/24
211.13 -32.02%
on 02/16/24
-7.43 (-4.92%)
since 11/07/23

Most Recent Stories

More News
Repligen Corporation to Present at Upcoming Investor Conferences

RGEN : 144.61 (-0.90%)
Repligen to Report Third Quarter 2024 Financial Results

RGEN : 144.61 (-0.90%)
Here's Why Shares in This Hot Healthcare Stock Surged This Week

The bioprocessing market is preparing for a recovery.

RGEN : 144.61 (-0.90%)
Repligen: Q2 Earnings Snapshot

Repligen: Q2 Earnings Snapshot

RGEN : 144.61 (-0.90%)
Broadcom, Korn Ferry rise; Signet Jewelers, Repligen fall, Thursday, 6/13/2024

Stocks that traded heavily or had substantial price changes on Thursday: Broadcom, Korn Ferry rise; Signet Jewelers, Repligen fall

OXM : 78.00 (-0.13%)
RGEN : 144.61 (-0.90%)
PLAY : 40.59 (-3.40%)
WLY : 52.06 (-0.65%)
SIG : 97.39 (+0.09%)
KFY : 78.57 (-1.00%)
AVGO : 183.34 (+2.11%)
Repligen: Q1 Earnings Snapshot

Repligen: Q1 Earnings Snapshot

RGEN : 144.61 (-0.90%)
Repligen: Q4 Earnings Snapshot

Repligen: Q4 Earnings Snapshot

RGEN : 144.61 (-0.90%)
How Good Is Your Market Cap Knowledge?

A company with a $50 price per share might have a million shares outstanding or a billion shares outstanding. And unless you know, you don't know the price tag of the stock you're about to buy.

NFLX : 795.95 (+2.02%)
INTU : 668.06 (+3.03%)
CLNE : 3.25 (-1.38%)
ALGN : 222.46 (-1.06%)
RGEN : 144.61 (-0.90%)
VRNS : 53.08 (-0.49%)
LMT : 550.97 (-0.15%)
DHR : 246.51 (-0.50%)
DPZ : 447.11 (+1.17%)
BR : 220.19 (+0.33%)
SHOP : 85.31 (+4.14%)
WMT : 84.13 (+0.83%)
Repligen: Q3 Earnings Snapshot

Repligen: Q3 Earnings Snapshot

RGEN : 144.61 (-0.90%)
Reviewing Mailbag Items and 5 Stocks Indistinguishable From Magic

September wasn't a good month for the stock market, but there's plenty for investors to talk about.

ASML : 677.68 (+2.46%)
NVDA : 147.94 (+1.60%)
RGEN : 144.61 (-0.90%)
PEGA : 85.87 (+0.20%)
SEDG : 14.55 (-0.89%)
WMT : 84.13 (+0.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies. Repligen earns revenues from the...

See More

Key Turning Points

3rd Resistance Point 160.59
2nd Resistance Point 155.68
1st Resistance Point 150.81
Last Price 144.61
1st Support Level 141.03
2nd Support Level 136.12
3rd Support Level 131.25

See More

52-Week High 211.13
Fibonacci 61.8% 173.84
Fibonacci 50% 162.32
Fibonacci 38.2% 150.79
Last Price 144.61
52-Week Low 113.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar